Brain Behavior & Immunity - Health,
Journal Year:
2024,
Volume and Issue:
43, P. 100923 - 100923
Published: Dec. 11, 2024
Schizophrenia
is
a
chronic
psychiatric
disorder
characterized
by
variety
of
symptoms
broadly
categorized
into
positive,
negative,
and
cognitive
domains.
Its
etiology
multifactorial,
involving
complex
interplay
genetic,
neurobiological,
environmental
factors,
its
neurobiology
associated
with
abnormalities
in
different
neurotransmitter
systems.
Due
to
this
multifactorial
neurobiology,
leading
wide
heterogeneity
clinical
presentations,
current
antipsychotic
treatments
face
challenges,
underscoring
the
need
for
novel
therapeutic
approaches.
Recent
studies
have
revealed
differences
gut
microbiome
individuals
schizophrenia
compared
healthy
controls,
establishing
an
intricate
link
between
gastrointestinal
health,
suggesting
that
microbiota-targeted
interventions
could
help
alleviate
symptoms.
Therefore,
meta-analysis
investigates
whether
microbiota
manipulation
can
ameliorate
psychotic
outcomes
patients
receiving
pharmacological
treatment.
Nine
(n
=
417
participants)
were
selected
from
81
records,
comprising
seven
randomized
controlled
trials
two
open-label
studies,
all
low
risk
bias,
included
systematic
review
meta-analysis.
The
overall
combined
effect
size
indicated
significant
symptom
improvement
following
treatment
(Hedges'
g
0.48,
95%
CI
0.09
0.88,
p
0.004,
I2
62.35%).
However,
according
Hedges'
criteria,
was
small
(approaching
moderate),
study
moderate
based
on
criteria.
This
also
discusses
preclinical
elucidate
neural,
immune,
metabolic
pathways
which
manipulation,
particularly
Lactobacillus
Bifidobacterium
genera,
may
exert
beneficial
effects
via
gut-brain
axis.
Finally,
we
address
main
confounding
factors
identified
our
review,
highlight
key
limitations,
offer
recommendations
guide
future
high-quality
larger
participant
cohorts
explore
microbiome-based
therapies
as
primary
or
adjunctive
schizophrenia.
Metabolites,
Journal Year:
2025,
Volume and Issue:
15(2), P. 127 - 127
Published: Feb. 13, 2025
Numerous
recent
studies
have
suggested
that
the
composition
of
intestinal
microbiota
can
trigger
metabolic
disorders,
such
as
diabetes,
prediabetes,
obesity,
syndrome,
sarcopenia,
dyslipidemia,
hyperhomocysteinemia,
and
non-alcoholic
fatty
liver
disease.
Since
then,
considerable
effort
has
been
made
to
understand
link
between
well
role
probiotics
in
modulation
microbiota.
The
aim
this
review
was
summarize
reviews
individual
articles
on
state
art
regarding
ideal
therapy
with
prebiotics
order
obtain
reversion
dysbiosis
(alteration
microbiota)
eubiosis
during
diseases,
diseases.
This
includes
245
eligible
studies.
In
conclusion,
a
condition
dysbiosis,
or
general,
alteration
microbiota,
could
be
implicated
development
disorders
through
different
mechanisms,
mainly
linked
release
pro-inflammatory
factors.
Several
already
demonstrated
potential
using
treatment
condition,
detecting
significant
improvements
specific
symptoms
These
findings
reinforce
hypothesis
lead
generalized
inflammatory
picture
negative
consequences
organs
systems.
Moreover,
confirms
beneficial
effects
diseases
are
promising,
but
more
research
is
needed
determine
optimal
probiotic
strains,
doses,
administration
forms
for
conditions.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(5), P. 929 - 929
Published: March 6, 2025
Objectives:
The
application
of
whole
fermented
foods
in
sports
nutrition
for
gut
microbiota
personalization
is
a
promising
area
investigation.
Sauerkraut,
traditional
food,
has
not
been
extensively
studied
this
context.
This
study
aimed
to
replicate
earlier
findings
proof-of-concept
on
the
potential
sauerkraut
active
athletes.
Methods:
A
pilot
follow-up
was
conducted
recreational
athletes
who
consumed
250
g
organic
pasteurized
daily
10
days.
Changes
composition
and
functionality
were
assessed
using
16S
rRNA
sequencing
metabolic
pathway
analysis
across
three
time
points:
pre-intervention,
postintervention,
one-month
postintervention.
Laboratory
parameters,
bowel
function,
side
effects
monitored
throughout
study.
Results:
In
total,
11
male
participants
with
an
average
age
30
years
completed
did
original
study's
sauerkraut's
short-term
β-diversity
taxonomic
functional
groups.
However,
long-term
supplementation
demonstrated,
including
significant
reduction
α-diversity
variance
increased
similarity
(β-diversity)
as
well
several
changes
bacterial
taxa
pathways
after
washout
period.
intervention
also
induced
transient
decrease
B12
vitamin
levels
short-
increase
leukocyte
concentrations.
probability
physiological
types
stools
one
week
incidence
gastrointestinal
effects,
such
bloating,
diarrhea,
pain,
nausea,
constipation.
Conclusions:
suggests
that
depend
its
baseline
status,
but
it
can
induce
effects.
Sauerkraut
requires
seven-day
adaptation
Further
research
needed
explore
mechanisms
behind
supplementation.
Applied Sciences,
Journal Year:
2025,
Volume and Issue:
15(6), P. 3157 - 3157
Published: March 14, 2025
Hepatitis
C
virus
(HCV)
accounts
for
approximately
17.5%
of
acute
hepatitis
cases,
with
around
65%
individuals
progressing
to
chronic
infection
after
the
phase.
The
role
intestinal
microbiota
in
pathogenesis
liver
diseases
associated
HCV
is
an
emerging
area
scientific
interest.
However,
precise
mechanisms
by
which
influence
remain
inadequately
understood,
warranting
further
investigation.
While
comprehensive
data
on
human
microbiota–HCV
interactions
are
limited,
existing
studies
provide
valuable
insights
that
can
inform
future
research
and
theoretical
exploration.
These
lay
foundation
hypothesizing
potential
linking
within
gut–liver
axis.
knowledge
regarding
between
remains
insufficient;
however,
recent
findings
highlight
significant
axis
progression
its
complications.
possible
therapeutic
advantages
strategies
modulate
microbiome,
such
as
fecal
transplantation
(FMT),
merit
investigation
relation
HCV.
Future
should
focus
elucidating
reciprocal
relationship
gut
pathogenesis,
identifying
microbial
markers
linked
disease
advancement,
assessing
effectiveness
microbiota-targeted
therapies
enhancing
clinical
outcomes
infected
This
review
aims
summarize
current
understanding
propose
a
novel
perspective
based
literature
findings,
thereby
paving
way
new
initiatives
infections.
We
surveyed
described
it
conducting
both
thematic
conceptual
analysis.
Frontiers in Microbiology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 3, 2025
Non-alcoholic
fatty
liver
disease
(NAFLD)
is
increasing
worldwide
and
has
become
the
greatest
potential
risk
for
cirrhosis
hepatocellular
carcinoma.
The
metabolites
produced
by
gut
microbiota
act
as
signal
molecules
that
mediate
interaction
between
microorganisms
host
have
biphasic
effects
on
human
health.
its
metabolites,
short-chain
acids
(SCFAs),
been
discovered
to
ameliorate
many
prevalent
diseases,
including
NAFLD.
Currently,
SCFAs
attracted
widespread
attention
therapeutic
targets
NAFLD,
but
mechanism
of
action
not
fully
elucidated.
This
article
summarizes
mechanisms
regulate
metabolism
glucose
lipid,
maintain
intestinal
barrier,
alleviate
inflammatory
response,
improve
oxidative
stress
in
order
provide
a
reference
clinical
application.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(7), P. 3332 - 3332
Published: April 3, 2025
Antimony
and
copper
can
contaminate
vegetables
enter
the
human
body
through
digestive
tract,
inducing
severe
extensive
biotoxicity.
However,
role
of
bile
acids
(BAs)
in
pathogenesis
liver
inflammation
by
antimony
or
has
not
been
elucidated.
Our
results
indicated
that
and/or
induced
inflammation,
causing
disruption
gut
microbiota,
with
down-regulation
probiotics
up-regulation
harmful
bacteria
closely
correlated
to
inflammation.
Targeted
metabolomics
BAs
showed
significantly
up-regulated
levels
taurine-β-muricholic
acid
(T-β-MCA)
serum
liver,
which
was
due
reduction
Lactobacillus
spp.
A
farnesoid
X
receptor
(FXR)
antagonist,
T-β-MCA
inhibited
FXR-SHP
pathway
FXR-FGF15
ileum,
thereby
promoting
transcription
cholesterol
7-alpha
hydroxylase
(CYP7A1)
increasing
total
concentrations,
ultimately
leading
These
findings
provide
new
insights
into
underlying
mechanisms
antimony-
copper-induced
Journal of Fungi,
Journal Year:
2025,
Volume and Issue:
11(5), P. 333 - 333
Published: April 22, 2025
The
gut
mycobiome,
the
fungal
component
of
microbiota,
plays
a
crucial
role
in
health
and
disease.
Although
fungi
represent
small
fraction
ecosystem,
they
influence
immune
responses,
homeostasis,
disease
progression.
mycobiome’s
composition
varies
with
age,
diet,
host
factors,
its
imbalance
has
been
linked
to
conditions
such
as
inflammatory
bowel
(IBD)
metabolic
disorders.
Advances
sequencing
have
expanded
our
understanding
fungi,
but
challenges
remain
due
methodological
limitations
high
variability
between
individuals.
Emerging
therapeutic
strategies,
including
antifungals,
probiotics,
fecal
microbiota
transplantation,
dietary
interventions,
show
promise
require
further
study.
This
review
highlights
recent
discoveries
on
interactions
bacteria,
disease,
potential
clinical
applications.
A
deeper
contributions
will
help
develop
targeted
microbiome-based
therapies.
Foods,
Journal Year:
2025,
Volume and Issue:
14(9), P. 1559 - 1559
Published: April 29, 2025
Neurodegenerative
disorders
such
as
Alzheimer’s
disease
(AD),
the
most
common
form
of
dementia,
represent
a
growing
global
health
crisis,
yet
current
treatment
strategies
remain
primarily
palliative.
Recent
studies
have
shown
that
neurodegeneration
through
complex
interactions
within
gut–brain
axis
largely
depends
on
gut
microbiota
and
its
metabolites.
This
review
explores
intricate
molecular
mechanisms
linking
dysbiosis
to
cognitive
decline,
emphasizing
impact
microbial
metabolites,
including
short-chain
fatty
acids
(SCFAs),
bile
acids,
tryptophan
neuroinflammation,
blood–brain
barrier
(BBB)
integrity,
amyloid-β
tau
pathology.
The
paper
highlights
major
microbiome
signatures
associated
with
disease,
detailing
their
metabolic
pathways
inflammatory
crosstalk.
Dietary
interventions
promise
in
modulating
composition,
potentially
mitigating
neurodegenerative
processes.
critically
examines
influence
dietary
patterns,
Mediterranean
Western
diets,
microbiota-mediated
neuroprotection.
Bioactive
compounds
like
prebiotics,
omega-3
polyphenols
exhibit
neuroprotective
effects
by
reducing
neuroinflammation.
Furthermore,
it
discusses
emerging
microbiome-based
therapeutic
strategies,
probiotics,
postbiotics,
fecal
transplantation
(FMT),
potential
for
slowing
progression.
Despite
these
advances,
several
knowledge
gaps
remain,
interindividual
variability
responses
need
large-scale,
longitudinal
studies.
study
proposes
an
integrative,
precision
medicine
approach,
incorporating
science
into
paradigms.
Ultimately,
cognizance
at
mechanistic
level
could
unlock
novel
avenues,
offering
non-invasive,
diet-based
strategy
managing
improving
health.
ABSTRACT
To
gain
more
light
on
the
effects
of
resveratrol
and
pterostilbene
in
hepatic
metabolic
modifications
an
vivo
model
diet‐induced
steatosis,
to
explore
their
relationships
with
gut
microbiota
by
untargeted
metabolomics
metagenomics.
Rats
were
divided
into
five
groups
receiving
either
a
standard
diet
or
high‐fat
high‐fructose
(HFHF)
supplemented
not
(15
30
mg/kg
body
weight/day;
PT15
PT30
groups,
respectively)
(30
RSV30
group).
Supplementation
stilbenes
reduced
steatosis
induced
HFHF
diet.
After
study,
27
differentially
expressed
metabolites
showed
variable
importance
projection
scores
>
1
could
be
considered
as
potential
biomarkers.
Therefore,
based
pathway
enrichment
analysis,
“riboflavin
metabolism”
“nicotinate
nicotinamide
revealed
significant
enrichment.
Further,
riboflavin
positive
correlations
Eubacterium
Faecalibacterium
,
negative
Lactobacillus
Oscillospira
genera.
Nicotinamide
mononucleotide
was
only
positively
correlated
Ralstonia
genus.
The
approach
that
actions
prevention
liver
are
mediated
specific
mechanisms
action.
Particularly,
pterostilbene,
but
resveratrol,
is
suggested
significantly
enrich
nicotinate
pathways.
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(11), P. 2256 - 2256
Published: Nov. 7, 2024
This
review
explores
the
complex
relationship
between
gut
dysbiosis
and
hematological
malignancies,
focusing
on
graft-versus-host
disease
(GvHD)
in
allogeneic
hematopoietic
stem
cell
transplantation
(allo-HSCT)
recipients.
We
discuss
how
alterations
microbial
diversity
composition
can
influence
development,
progression,
treatment
outcomes
blood
cancers.
The
mechanisms
by
which
microbiota
impacts
these
conditions
are
examined,
including
modulation
of
immune
responses,
production
metabolites,
effects
intestinal
barrier
function.
Recent
advances
microbiome-based
therapies
for
treating
preventing
GvHD
highlighted,
with
emphasis
full
ecosystem
standardized
donor-derived
products.
Overall,
this
underscores
growing
importance
microbiome
research
hematology–oncology
its
potential
to
complement
existing
treatments
improve
thousands
patients
worldwide.
Medicina,
Journal Year:
2024,
Volume and Issue:
60(12), P. 1969 - 1969
Published: Nov. 29, 2024
Dysbiosis
of
the
gastrointestinal
tract
is
most
common
cause
disease
in
childhood
and
adulthood.
The
formation
intestinal
microbiome
begins
utero,
composition
modification
during
life
depends
mainly
on
various
genetic,
nutritional,
environmental
factors.
main
dysbiosis
improper
nutrition
due
to
a
short
period
breastfeeding,
insufficient
intake
fresh
fruits
vegetables,
and/or
consumption
large
amount
processed
food.
benefits
diet
based
grains,
legumes,
fruits,
vegetables
are
reflected
reducing
risk
cancer,
cardiovascular
diseases,
myocardial
infarction,
stroke,
rheumatoid
arthritis,
high
blood
pressure,
asthma,
allergies,
kidney
stones.
Anaerobic
fermentation
fibers
produces
short-chain
fatty
acids
(SCFA)
that
have
an
anti-inflammatory
role
great
importance
shaping
microbiota.
Factors
associated
with
fiber
plant-based
promote
increased
insulin
sensitivity.
Insulin
insulin-like
growth
factor
1
(IGF-I)
act
as
promoters
normal
pre-neoplastic
tissues.
Conclusion:
A
prevents
by
creating
metabolites
gut
reduce
oxidative
stress.